Learn more about how the BASHIR™ endovascular catheter can be used in a dual therapy mode for the treatment of heavily thrombosed VTE patients from prominent thought leaders and physicians. In this clip, Dr. Anthony Comerota, Dr. David Dexter, and Dr. Patrick Muck discuss how the BASHIR™ endovascular catheter optimizes the way r-tPA therapy is leveraged for increased safety and efficacy. Learn how this cost-effective hybrid catheter enables a shorter duration of infusion, minimizes the dosage of r-tPA required, and optimizes clot burden resolution.

​

Efthymios "Makis" Avgerinos, MD, FACS, FEBVS

Dr. Anthony Comerota, MD, FACS, FACC 

Dr. David Dexter, MD, FACS

Dr. Patrick Muck, MD, RVT, FACS

​